These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21500241)

  • 1. The use of mass spectrometry to study amyloid-β peptides.
    Grasso G
    Mass Spectrom Rev; 2011; 30(3):347-65. PubMed ID: 21500241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
    Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
    J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metals, membranes, and amyloid-β oligomers: key pieces in the Alzheimer's disease puzzle?
    Watt AD; Villemagne VL; Barnham KJ
    J Alzheimers Dis; 2013; 33 Suppl 1():S283-93. PubMed ID: 22699851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of ε-viniferin on β-amyloid peptide aggregation investigated by electrospray ionization mass spectrometry.
    Richard T; Poupard P; Nassra M; Papastamoulis Y; Iglésias ML; Krisa S; Waffo-Teguo P; Mérillon JM; Monti JP
    Bioorg Med Chem; 2011 May; 19(10):3152-5. PubMed ID: 21524590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid oxidation and modification of amyloid-β (Aβ) in vitro and in vivo.
    Ellis G; Fang E; Maheshwari M; Roltsch E; Holcomb L; Zimmer D; Martinez D; Murray IV
    J Alzheimers Dis; 2010; 22(2):593-607. PubMed ID: 20847409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretases as therapeutic targets for Alzheimer's disease.
    Woo HN; Baik SH; Park JS; Gwon AR; Yang S; Yun YK; Jo DG
    Biochem Biophys Res Commun; 2011 Jan; 404(1):10-5. PubMed ID: 21130746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
    Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
    Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling effect of a γ-secretase inhibitor on amyloid-β dynamics reveals significant role of an amyloid clearance mechanism.
    Das R; Nachbar RB; Edelstein-Keshet L; Saltzman JS; Wiener MC; Bagchi A; Bailey J; Coombs D; Simon AJ; Hargreaves RJ; Cook JJ
    Bull Math Biol; 2011 Jan; 73(1):230-47. PubMed ID: 20411345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do amyloid β-associated factors co-deposit with Aβ in mouse models for Alzheimer's disease?
    Timmer NM; Kuiperij HB; de Waal RM; Verbeek MM
    J Alzheimers Dis; 2010; 22(2):345-55. PubMed ID: 20847441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological characteristics of amyloid precursor protein and Alzheimer's disease].
    Fukatsu R; Tsuzuki K; Takamaru Y; Hayashi Y; Sasaki N; Yoshida T; Midorikawa Y; Fujii N; Takahata N
    Rinsho Byori; 1996 Mar; 44(3):213-24. PubMed ID: 8857163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.
    Tõugu V; Tiiman A; Palumaa P
    Metallomics; 2011 Mar; 3(3):250-61. PubMed ID: 21359283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods for analysis of amyloid-β aggregates.
    Bruggink KA; Müller M; Kuiperij HB; Verbeek MM
    J Alzheimers Dis; 2012; 28(4):735-58. PubMed ID: 22156047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel APP/Abeta isoforms in human cerebrospinal fluid.
    Portelius E; Brinkmalm G; Tran AJ; Zetterberg H; Westman-Brinkmalm A; Blennow K
    Neurodegener Dis; 2009; 6(3):87-94. PubMed ID: 19229112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42).
    Sultana R; Perluigi M; Butterfield DA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 833(1):3-11. PubMed ID: 16236561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Production and catabolism of amyloid peptides in Alzheimer's disease].
    Checler F
    Therapie; 2010; 65(5):409-14. PubMed ID: 21144475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-Secretase, APP and Abeta in Alzheimer's disease.
    Vassar R
    Subcell Biochem; 2005; 38():79-103. PubMed ID: 15709474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
    Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
    J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cu(II) interaction with amyloid-beta peptide: a review of neuroactive mechanisms in AD brains.
    Lin CJ; Huang HC; Jiang ZF
    Brain Res Bull; 2010 Jul; 82(5-6):235-42. PubMed ID: 20598459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.